Publications and patents

  • Publications
  • Patents
  • 2023年
    Yonehara, R., Kumachi, S., Kashiwagi, K., Wakabayashi-Nakao, K., Motohashi, M., Murakami, T., Yanagisawa, T., Arai, H., Murakami, A., Ueno, Y., Nemoto, N., & Tsuchiya, M. (2023). A novel agonist with homobivalent single-domain antibodies that bind the FGF receptor 1 domain III functions as an FGF2 ligand. The Journal of biological chemistry, 299(2), 102804. https://doi.org/10.1016/j.jbc.2022.102804
  • 2022年
    Murakami T, Kumachi S, Matsunaga Y, Sato M, Wakabayashi-Nakao K, Masaki H, Yonehara R, Motohashi M, Nemoto N, Tsuchiya M., Construction of a Humanized Artificial VHH Library Reproducing Structural Features of Camelid VHHs for Therapeutics. Antibodies, 11(1), 10 (2022)
  • 2021年

    Haga K, Takai-Todaka R, Matsumura Y, Song C, Takano T, Tojo T, Nagami A, Ishida Y, Masaki H, Tsuchiya M, Ebisudani T, Sugimoto S, Sato T, Yasuda H, Fukunaga K, Akihito Sawada A, Nemoto N, Murata K, Morimoto T, Katayama K., Nasal delivery of single-domain antibody improves symptoms of SARS-CoV-2 infection in an animal model. PLOS Pathogens, https://doi.org/10.1371/journal.ppat.1009542

    Anzai H, Terai T, Wakabayashi-Nakao K, Noguchi T, Kumachi S, Tsuchiya M, Nemoto N., Interleukin-17A Peptide Aptamers with an Unexpected Binding Moiety Selected by cDNA Display under Heterogenous Conditions. ACS Med. Chem. Lett., 12, 1427-1434 (2021)

  • 2020年

    Jayathilake C, Kumachi S, Arai H, Motohashi M, Terai T, Murakami A, Nemoto N., In vitro selection of anti-gliadin single-domain antibodies from a naïve library for cDNA-display mediated immuno-PCR. Analytical Biochemistry, 589, 113490 (2020)

    Arai H, Kumachi S, Nemoto N., cDNA Display: A Stable and Simple Genotype-Phenotype Coupling Using a Cell-Free Translation System. Methods in Mol. Biol., 2070, 43-56, 2020

  • 2018年

    Nemoto N, Kumachi S, Arai H., In vitro Selection of Single-Domain Antibody (VHH) using cDNA display, “Antibody Engineering 3rd Edition (edited by D. Nevoltis & P. Chames)”, Methods in Mol. Biol., 1827, 269-285 (2018)

    Suzuki T, Nochizuki Y, Kimura S, Akazawa-Ogawa Y, Hagihara Y, Nemoto N., Anti-survivin single-domain antibodies derived from an artificial library including three synthetic random regions by in vitro selection using cDNA display, Biochem. Biophys. Res. Commun., 503, 3, 2054-2060 (2018)

  • 2017年

    Kobayashi S, Terai T, Yoshikawa Y, Ohkawa R, Edihara M, Hayashi M, Takiguchi K, Nemoto N., In vitro selection of random peptides against artificial lipid bilayers: a potential tool to immobilize molecules on membranes, Chem. Commun. (Camb.), 53, 3458-3461 (2017)

  • 2016年

    Kumachi S, Husimi Y, Nemoto N., An RNA Binding Peptide Consisting of Four Types of Amino Acid by in Vitro Selection Using cDNA Display. ACS Omega. 1, 52-57 (2016)

  • 2015年

    Mochizuki Y, Suzuki T, Fujimoto K, Nemoto N., A Versatile puromycin-linker using cnvK for high-throughput in vitro selection by cDNA display. J. Biotechnol. 212, 174-180 (2015)

    Tanemura Y, Mochizuki Y, Kumachi S, Nemoto N., Easy and rapid binding assay for fanctional analysis of disulfide-containing peptides by a pull-down method using a puromycin-linker and a cell-free translation system, Biology (Basel), 4, 161-172 (2015)

  • 2014年

    Nemoto N, Fukushima T, Kumachi S, Suzuki M, Nishigaki K, kubo T., Versatile C-terminal specific biotinylation of proteins using both a puromycin-linker and a cell-free translation system for studying high-throughput protein-molecule interations, Anal. Chem., 86, 8535-8540 (2014)

    Mochizuki Y, Nisigaki K, Nemoto N., Amino group binding peptide aptamers with double disulphide-bridged loops selected by in vitro selection using cDNA display., Chem. Commun. (Camb.), 50, 5608-5610 (2014)

  • 2013年

    Mochizuki Y, Kohno F, Nishigaki K, Nemoto N., A pull-down method with a biotinylated bait protein prepared by cell-free translation using a puromycin linker. Anal. Biochem., 434, 93-95 (2013)

  • 2012年

    Ueno S, Kimura S, Ichiki T, Nemoto N., Improvement of a puromycin-linker to extend the selestion target varieties in cDNA display method. J. Biotechnol., 162, 299-302 (2012)

    Ueno S, Yoshida S, Mondal A, Nishina K, Koyama M, Sakata I, Miura K, Hayashi Y, Nemoto N, Nishigaki K, Sakai T., In vitro selestion of a peptide antagonist of growth hormone secretagogue receptor using cDNA display. Proc. Natl. Acad. Sci. USA, 109, 11121-11126 (2012)

    Nemoto N, Tsutsui C, Yamaguchi J, Ueno S, Machida M, Kobayashi T, Sakai T., Antagonistic effect of disulfide-rich peptide aptamers selected by cDNA display on inetrleukin-6-dependent cell proliferation. Biochem. Biophys. Res. Commun.. 421, 129-133 (2012)

    Ueno S, Nemoto N., cDNA display: rapid stablilization of mRNA display. Methods in Mol. Biol., 805, 113-135 (2012)

    Mochizuki Y, Nemoto N., Evolution of disulfide-rich peptide aptamers using cDNA display. Methods in Mol. Biol., 805, 237-250 (2012)

  • 2011年

    Mochizuki Y, Biyani M, Tsuji-Ueno S, Suzuki M, Nishigaki K, Husimi Y, Nemoto N., One-pot preparation of mRNA/cDNA display by a novel and versatile puromycin-linker DNA. ACS Comb. Sci., 13, 478-485 (2011)

    Naimuddin M, Kobayashi S, Tsutsui C, Machida M, Nemoto N, Sakai T, Kubo T., Directed evolution of a three-finger neurotoxin by using cDNA display yields antagonists as well as agonists of interleukin-6 receptor signaling. Mol. Brain., 4, 2 (2011)

  • 2009年
    Yamaguchi J, Naimuddin M, Biyani M, Sasaki T, Machida M, Kubo T, Funatsu T, Husimi Y, Nemoto N., cDNA display: a novel screening method for functional disulfide-rich peptides by solid-phase synthesis and stabilization of mRNA-protein fusions. Nucleic Acids Res.. 16, e108 (2009)
  • 1997年
    Nemoto N, Miyamoto-Sato E, Husimi Y, Yanagawa H., In vitro virus: bonding of mRNA bearing puromycin at the 3´-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro. FEBS Lett. 414, 405-408 (1997)
Coming Soon
Contact Us

If you have any questions about our service/need more information about joint research or licesing business, please feel free to contact us via the contact form below.